Cadrenal Therapeutics, Inc. Common Stock (CVKD)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $5.39M
Last updated: Nov 17, 2026 at 11:02 AM ET
Cadrenal Therapeutics, Inc. Common Stock (CVKD) Competitors
The companies most similar to Cadrenal Therapeutics, Inc. Common Stock are Cardio Diagnostics Holdings (CDIO), SeaStar Medical Holding (ICU) and PharmaCyte Biotech (PMCB). By market cap, Cadrenal Therapeutics, Inc. Common Stock ranks 6th of the 13 companies on this page; Biocardia (BCDA) is the largest at $12.58M.
Peer Comparison
CVKD's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Cadrenal Therapeutics, Inc. Common Stock (CVKD) | $5.39M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Cardio Diagnostics Holdings Inc (CDIO) | $5.59M | N/A | 348.9x | 0.0% | N/A | 25.7% | 0.00% |
| SeaStar Medical Holding Corporation (ICU) | $4.46M | N/A | 1.7x | 0.0% | N/A | 82.0% | 0.00% |
| PharmaCyte Biotech Inc (PMCB) | $3.77M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Reviva Pharmaceuticals Holdings Inc. (RVPH) | $4.63M | N/A | N/A | 0.0% | -90.2% | 0.0% | 0.00% |
| Kiora Pharmaceuticals Inc (KPRX) | $5.44M | N/A | 6.2x | 0.0% | N/A | 0.0% | 0.00% |
| Biocardia Inc (BCDA) | $12.58M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| CNS Pharmaceuticals Inc (CNSP) | $4.22M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Theriva Biologics Inc. (TOVX) | $6.61M | N/A | 21.5x | 0.0% | -52.3% | 0.0% | 0.00% |
| VistaGen Therapeutics Inc (VTGN) | $8.01M | N/A | 3.4x | 0.0% | N/A | -46.5% | 0.00% |
| Skye Bioscience, Inc. Common Stock (SKYE) | $4.83M | N/A | N/A | 0.0% | -3685.3% | 0.0% | 0.00% |
| Creative Medical Technology Holdings Inc (CELZ) | $4.01M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Curis Inc (CRIS) | $2.97M | N/A | 1.6x | 0.0% | N/A | -66.0% | 0.00% |
| Peer median | $4.73M | N/A | 4.8x | 0.0% | -90.2% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Cadrenal Therapeutics, Inc. Common Stock, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Cardio Diagnostics Holdings Inc (CDIO) | Cardio Diagnostics Holdings Inc (CDIO) is a pioneering biotechnology firm focused on enhancing cardiovascular health through innovative diagnostic solutions. | CDIO competitors |
| SeaStar Medical Holding Corporation (ICU) | SeaStar Medical Holding Corporation (ICU) is a forward-looking biotechnology company dedicated to innovating treatment solutions for chronic kidney disease via... | ICU competitors |
| PharmaCyte Biotech Inc (PMCB) | PharmaCyte Biotech, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cell therapies for cancer and diabetes in the United... | PMCB competitors |
| Reviva Pharmaceuticals Holdings Inc. (RVPH) | Reviva Pharmaceuticals Holdings Inc. (RVPH) is a clinical-stage biopharmaceutical company dedicated to developing groundbreaking therapies for central nervous... | RVPH competitors |
| Kiora Pharmaceuticals Inc (KPRX) | Kiora Pharmaceuticals Inc. is a clinical-stage biotechnology firm focused on developing innovative therapies for ocular diseases and neurodegenerative... | KPRX competitors |
| Biocardia Inc (BCDA) | BioCardia, Inc., a clinical-stage regenerative medicine company, develops therapies for cardiovascular disease. | BCDA competitors |
| CNS Pharmaceuticals Inc (CNSP) | CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, is dedicated to the development of cancer drug candidates for the treatment of brain and central... | CNSP competitors |
| Theriva Biologics Inc. (TOVX) | Theriva Biologics Inc., a clinical-stage company, develops therapies to treat diseases in areas of high unmet need. | TOVX competitors |
| VistaGen Therapeutics Inc (VTGN) | VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing and commercializing several drugs with the potential... | VTGN competitors |
| Skye Bioscience, Inc. Common Stock (SKYE) | Skye Bioscience, Inc., a clinical stage biopharmaceutical company, discovers, develops... | SKYE competitors |
| Creative Medical Technology Holdings Inc (CELZ) | Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics... | CELZ competitors |
| Curis Inc (CRIS) | Curis, Inc., a biotechnology company, is dedicated to the discovery and development of drug candidates for the treatment of human cancers in the United States. | CRIS competitors |
Frequently Asked Questions About CVKD
Who are Cadrenal Therapeutics, Inc. Common Stock's main competitors?
The companies most similar to Cadrenal Therapeutics, Inc. Common Stock include Cardio Diagnostics Holdings (CDIO), SeaStar Medical Holding (ICU), PharmaCyte Biotech (PMCB), Reviva Pharmaceuticals Holdings (RVPH) and Kiora Pharmaceuticals (KPRX), listed from the closest match.
Who is Cadrenal Therapeutics, Inc. Common Stock's biggest competitor?
Biocardia (BCDA) is the largest of the similar companies at $12.58M; Cardio Diagnostics Holdings (CDIO) is the closest match by business profile, size, sector and industry.
How does CVKD stock compare with its competitors?
CVKD's net margin is 0.0% against a peer median of 0.0%.
Which of Cadrenal Therapeutics, Inc. Common Stock's competitors pays a higher dividend?
Cadrenal Therapeutics, Inc. Common Stock pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Cadrenal Therapeutics, Inc. Common Stock bigger than its competitors?
No. Cadrenal Therapeutics, Inc. Common Stock is 6th by market cap among the 13 companies on this page; the largest is Biocardia (BCDA) at $12.58M.
CVKD pages: Overview, Earnings, Forecast, Competitors